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Yeducation, nutritional, medical, psychological and sexual counseling and group
smoking cessation. All patients participated in low intensity exercise program twice
weekly. The patient’s symptoms, vitals and medications were evaluated at each
visit and clinical and laboratory data, echocardiography and stress myocardial perfu-
sion imaging (SPECT) were evaluated before and 3 months after the end of the study.
RESULTS The mean age was 56.83.1 years and only 2 patients (5%) were females.
22(55%) patients were diabetic, 21 (53%) were hypertensive and 30 (75%) were
smokers. It was found that 3 months after completion of CRP, there was a signiﬁcant
decrease in BMI (30.32.9 vs. 31.21.9, p<0.001), and mean blood pressure (93.411
vs. 10510.6 mmHg, p<0.001). There was also a favorable effect on lipid proﬁle and a
signiﬁcant improvement of the functional capacity in terms of NYHA functional class
(2.10.62 vs. 1.40.6, p<0.001). Despite that wall motion score index did not
signiﬁcantly change after CRP, there was a strong trend towards a better ejection
fraction (53.77.8 vs. 54.56.3 %, p¼0.06) and signiﬁcant improvement of Canadian
cardiovascular class (1.420.6 vs. 1.950.5, p<0.001) post CRP. Importantly, the
difference between the SPECT-derived summed segmental scores at peak stress and
at rest (SDS) was signiﬁcantly lower after CRP (4.43 vs. 7.23, p<0.001).
CONCLUSION Participation in cardiac rehabilitation program improves ischemic
burden in patients with IHD who are unﬁt or not suitable for conventional cardiac
revascularization. In addition the decreased ischemic burden, functional capacity,
hemodynamic and metabolic proﬁles also improves for this group of patients and
thus, cardiac rehabilitation should be implemented for routine management of those
patients.
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BACKGROUND Coronary artery calciﬁcation (CAC) is an established risk factor for
poor cardiovascular clinical outcomes. This economic modeling analysis estimates
the incremental impact of CAC on medical care costs and patient mortality for de novo
percutaneous coronary intervention (PCI) patients in the 2012 cohort of the Medicare
elderly (>65) population.
METHODS The target study population is the Medicare elderly with atherosclerosis in
calendar year 2012 experiencing a new index event, deﬁned as a patient receiving a
coronary angiogram with no prior coronary revascularization in the preceding six
months. This aggregate burden of illness study is incidence-based, focusing on cost
and survival outcomes for an annual Medicare cohort based on the recently intro-
duced ICD9 code for CAC. The horizon of the cost analysis uses a one-year horizon,
and the survival analysis considers lost life years and their economic value. The
principal data sources for cost and survival analyses were Medicare’s Standard Ana-
lytic Files. Estimates of the degree of calciﬁcation and the incidence of MACE were
based on the HORIZONS-AMI/ACUITY elderly pooled sample.
RESULTS For calendar year 2012, an estimated 200,945 index (de novo) PCI pro-
cedures were performed in this cohort. An estimated 16,000 Medicare beneﬁciaries
(7.9%) were projected to have had severe CAC generating an additional cost in the
ﬁrst year following their PCI of $3,500, on average, or $56 million in total. In terms of
mortality, the model projects an additional 397 deaths would be attributable to severe
CAC in 2012, resulting in 3,770 lost life years, representing an estimated loss of about
$377 million, when valuing lost life years at $100,000 each. An estimated 63,000
patients had moderate CAC.
CONCLUSIONS These model-based CAC estimates, considering both moderate and
severe CAC patients, suggest an annual burden of illness approaching $1.3 billion in
this PCI cohort. The potential clinical and cost consequences of CAC warrant addi-
tional clinical and economic attention not only on PCI strategies for appropriate pa-
tients but also on reporting and coding to achieve better evidence-based decision
making.
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Is the Allen Test Necessary Before Transradial Artery Catheterization?
Ersin Saricam,1 Osman Beton,2 Yasemin Saglam,1 Orhan Dogdu,3 Birhan Yilmaz4
1Private Cag Hospital, Ankara, Turkey; 2Diskapi Yildirim Beyazit Research and Training
Hospital, Ankara, Turkey; 3Firat University, Faculty of Medicine, Department of
Cardiology, Elazig, Turkey; 4Cumhuriyet University, Faculty of Medicine, Department
of Cardiology, Sivas, TurkeyOBJECTIVE We investigated whether Allen test is necessary before transradial
approach.
BACKGROUND Transradial approach has been feasible and effective for cardiac and
other vascular interventions in recent years. Most operators use a modiﬁed Allen
test due to known collateral circulation in the hand; however, the deﬁnition of
abnormal Allen test is not consistent and necessity before radial cannulation is not
well deﬁned.
METHODS The study population consisted of 2650 patients who had been per-
formed cardiac catheterization or peripheral angiography (abdominal aortic, lower
extremity) via radial access between 2011 and 2013. All of the patients were retro-
spectively investigated. Sixty ﬁve patients (Group A) had abnormal Allen test before
transradial catheterization. One hundred and thirty age, sex and risk factors
matched patients who had normal Allen test before transradial catheterization was
taken as control group (Group B). No other test was used to assess collateral cir-
culation in the hand. Standard cannulation techniques were used. One month after
the procedure, all of the patients were performed Doppler ultrasonography for
radial artery ﬂow.
RESULTS Procedural success was similar between both groups (96.9% and 98.5%,
p¼0.367), and no major complication (subacute or delayed occlusion, spasm, hema-
toma, compartment syndrome, perforation/laceration/dissection, avulsion, AV
ﬁstula, pseudoaneurysm, digital ischemia, transient vocal cord paralysis) was
developed in both groups during and after the procedure. Minor complications
(subcutaneous edema, paresthesia, and ecchymosis) were developed in three patients
in group A. However, none of them required surgical intervention. Doppler ultraso-
nography showed normal radial ﬂow patterns in both study groups at one month
post-procedural follow-up.
CONCLUSION Allen test may not be necessary before transradial access.CRT-174
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BACKGROUND Transradial access for coronary angiography is widely used because of
the low risk of complications and faster ambulation times for patients. Ulnar artery
can also be easily accessed for coronary angiography. We compared the safety and
efﬁcacy of this approach in this meta-analysis.
METHODS PubMed, EBSCO and Google Scholar databases were queried for studies on
transradial and transulnar access. Efﬁcacy and adverse events for both these routes were
then extracted and analyzed with Revman 5.2 software using random effects model.
RESULTS A total of 7 studies with 13,285 patients were included in this meta-
analysis. There was a high percentage of successful radial artery access with a very
low risk of crossover to alternate site compared to ulnar artery access (OR 0.32, 95%
CI 0.12-0.91). This was driven by a high crossover rate in the ulnar group in one
particular study. The number of attempts needed to gain successful access was very
similar between the two groups (mean difference ¼ -0.18, 95% CI -0.27-0.09). The
incidence of complications such as hematomas (OR 0.81, 95% CI 0.41-1.61), arterial
spasm (OR 1.21, 95% CI, 0.47-3.14), arterial occlusion (OR 0.93, 95% CI 0.68-1.28)
and major adverse cardiovascular events (OR 1.17, 95% CI 0.73-1.86) were similar in
both groups.
CONCLUSION There was a lower incidence of crossover with the radial access compared
to ulnar. However, the complication rates were similar between the two groups.
